These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9858220)

  • 1. Chromosomal abnormalities in systemic amyloidosis.
    Fonseca R; Ahmann GJ; Jalal SM; Dewald GW; Larson DR; Therneau TM; Gertz MA; Kyle RA; Greipp PR
    Br J Haematol; 1998 Dec; 103(3):704-10. PubMed ID: 9858220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition.
    Zandecki M; Laï JL; Geneviève F; Bernardi F; Volle-Rémy H; Blanchet O; François M; Cosson A; Bauters F; Facon T
    Blood; 1997 Nov; 90(9):3682-90. PubMed ID: 9345053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance.
    Drach J; Angerler J; Schuster J; Rothermundt C; Thalhammer R; Haas OA; Jäger U; Fiegl M; Geissler K; Ludwig H; Huber H
    Blood; 1995 Nov; 86(10):3915-21. PubMed ID: 7579361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic abnormalities in monoclonal gammopathy of undetermined significance.
    Fonseca R; Bailey RJ; Ahmann GJ; Rajkumar SV; Hoyer JD; Lust JA; Kyle RA; Gertz MA; Greipp PR; Dewald GW
    Blood; 2002 Aug; 100(4):1417-24. PubMed ID: 12149226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells.
    Zandecki M; Obein V; Bernardi F; Soenen V; Flactif M; Laï JL; François M; Facon T
    Br J Haematol; 1995 Jul; 90(3):693-6. PubMed ID: 7647011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies.
    Ahmann GJ; Jalal SM; Juneau AL; Christensen ER; Hanson CA; Dewald GW; Greipp PR
    Cancer Genet Cytogenet; 1998 Feb; 101(1):7-11. PubMed ID: 9460493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.
    Drach J; Schuster J; Nowotny H; Angerler J; Rosenthal F; Fiegl M; Rothermundt C; Gsur A; Jäger U; Heinz R
    Cancer Res; 1995 Sep; 55(17):3854-9. PubMed ID: 7641204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.
    Harrison CJ; Mazzullo H; Ross FM; Cheung KL; Gerrard G; Harewood L; Mehta A; Lachmann HJ; Hawkins PN; Orchard KH
    Br J Haematol; 2002 May; 117(2):427-35. PubMed ID: 11972529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Li JY; Morineau N; Facon T; Brigaudeau C; Harousseau JL; Grosbois B; Bataille R
    Blood; 1999 Oct; 94(8):2583-9. PubMed ID: 10515861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
    Hayman SR; Bailey RJ; Jalal SM; Ahmann GJ; Dispenzieri A; Gertz MA; Greipp PR; Kyle RA; Lacy MQ; Rajkumar SV; Witzig TE; Lust JA; Fonseca R
    Blood; 2001 Oct; 98(7):2266-8. PubMed ID: 11568015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis.
    Fonseca R; Rajkumar SV; Ahmann GJ; Jalal SM; Hoyer JD; Gertz MA; Kyle RA; Greipp PR; Dewald GW
    Leuk Lymphoma; 2000 Oct; 39(3-4):391-5. PubMed ID: 11342320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
    Bernasconi P; Cavigliano PM; Boni M; Astori C; Calatroni S; Giardini I; Rocca B; Caresana M; Crosetto N; Lazzarino M; Bernasconi C
    Br J Haematol; 2002 Aug; 118(2):545-9. PubMed ID: 12139743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.